According to the FDA prescribing label, reactions such as injection-site discomfort and erythema (redness) were reported in placebo-controlled trials
"Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis"
Eyelid Twitching Some patients taking Wegovy may experience eye twitching, a condition known as eyelid twitching or myokymia
Contact your pharmacist if you notice any visible changes in the medication's appearance , including discoloration (any color other than clear to slightly yellow), cloudiness in a solution that should be clear, visible particles or precipitates, or cracks in the vial
Retatrutide targets three receptors (GIP, GLP-1, and glucagon), potentially offering enhanced benefits
Regulatory compliance separates survivors from casualties